Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05394363Recruiting

Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents

Role: collaborator

NCT06398951Not ApplicableActive Not Recruiting

HFNC vs Two Nare HFNC in Extubated Patients

Role: lead

NCT06321497Recruiting

Extracorporeal Carbon Dioxide Removal Using PrismaLung in Reducing Ventilator Induced Lung Injury

Role: lead

NCT02280382Not ApplicableCompleted

An Intervention to Improve Prolapse Using Femmeze® (v1)

Role: collaborator

NCT02474524Not ApplicableCompleted

Self-Management and Recovery Technology Psychosocial Intervention Trial

Role: collaborator

All 5 trials loaded